Potential Drug Targets for SLCO4A1 (OATP-RP1) (G28231)

Target Name: SLCO4A1

NCBI ID: G28231

SLCO4A1

Potential Drug Targets for SLCO4A1 (OATP-RP1)

SLCO4A1 (OATP-RP1) is a gene that encodes a protein known as SNORD2, which is a subunit of the Na+/K+-ATPase (Na+-K+-ATPase) gene. The Na+/K+-ATPase is a transmembrane protein that is involved in the regulation of intracellular fluid balance, and is a key component of the cell's energy metabolism.

SLCO4A1 (OATP-RP1) has been identified as a potential drug target or biomarker for several diseases, including heart failure, hypertension, and diabetes. Its functions in these diseases, as well as its role in the regulation of intracellular fluid balance, make it an attractive target for the development of new therapeutic approaches.

One of the key reasons why SLCO4A1 (OATP-RP1) has been identified as a potential drug target is its role in the regulation of intracellular fluid balance. The Na+/K+-ATPase is responsible for maintaining the levels of intracellular and extracellular fluids, and is involved in the regulation of water and electrolyte balance. Imbalances in the levels of these fluids can have serious consequences for the health of the body, including increased risk of developing cardiovascular disease, hypertension, and diabetes.

SLCO4A1 (OATP-RP1) has been shown to play a key role in the regulation of intracellular fluid balance by controlling the activity of the Na+/K+-ATPase. Studies have shown that the levels of the Na+/K+-ATPase are increased in individuals with heart failure, hypertension, and diabetes, and that the activity of this enzyme is decreased in individuals with these conditions. By targeting the Na+/K+-ATPase with drugs that inhibit its activity, it may be possible to develop new therapeutic approaches for the treatment of these diseases.

Another potential reason why SLCO4A1 (OATP-RP1) has been identified as a potential drug target is its role in the regulation of cell signaling. The Na+/K+-ATPase is involved in the regulation of several cellular processes, including cell signaling, cell growth, and cell death. Imbalances in the levels of this enzyme can have serious consequences for the health of the body, including the development of cancer.

SLCO4A1 (OATP-RP1) has been shown to play a key role in the regulation of cell signaling by controlling the activity of the Na+/K+-ATPase. Studies have shown that the levels of the Na+/K+-ATPase are increased in individuals with certain types of cancer, and that the activity of this enzyme is decreased in individuals with these conditions. By targeting the Na+/K+-ATPase with drugs that inhibit its activity, it may be possible to develop new therapeutic approaches for the treatment of these cancers.

In addition to its role in the regulation of intracellular fluid balance and cell signaling, SLCO4A1 (OATP-RP1) has also been shown to play a key role in the regulation of cell growth and cell death. Imbalances in the levels of this enzyme can have serious consequences for the health of the body, including the development of cancer.

SLCO4A1 (OATP-RP1) has been shown to play a key role in the regulation of cell growth and cell death by controlling the activity of the Na+/K+-ATPase. Studies have shown that the levels of the Na+/K+-ATPase are increased in individuals with certain types of cancer, and that the activity of this enzyme is decreased in individuals with these conditions. By targeting the Na+/K+-ATPase with drugs that inhibit its activity, it may be possible to develop new therapeutic approaches for the treatment of these cancers.

Overall, SLCO4A1 (OATP-RP1) is a gene that encodes a protein involved in the regulation of

Protein Name: Solute Carrier Organic Anion Transporter Family Member 4A1

Functions: Mediates the Na(+)-independent transport of organic anions such as the thyroid hormones T3 (triiodo-L-thyronine), T4 (thyroxine) and rT3, taurocholate, estrone 3-sulfate, estradiol-17beta-glucuronide and prostaglandin E2 (PGE2) (PubMed:10873595, PubMed:19129463). Shows a pH-sensitive substrate specificity T4 and estrone 3-sulfate which may be ascribed to the protonation state of the binding site and leads to a stimulation of substrate transport in an acidic microenvironment (PubMed:19129463). Hydrogencarbonate/HCO3(-) acts as the probable counteranion that exchanges for organic anions (PubMed:19129463). May contribute to regulate the transport of organic compounds in testes across the blood-testis-barrierr (Probable)

The "SLCO4A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLCO4A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets